CL2007003232A1 - COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS. - Google Patents
COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.Info
- Publication number
- CL2007003232A1 CL2007003232A1 CL200703232A CL2007003232A CL2007003232A1 CL 2007003232 A1 CL2007003232 A1 CL 2007003232A1 CL 200703232 A CL200703232 A CL 200703232A CL 2007003232 A CL2007003232 A CL 2007003232A CL 2007003232 A1 CL2007003232 A1 CL 2007003232A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- hydroximethyl
- oxazolidin
- ona
- treat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2006054189 | 2006-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007003232A1 true CL2007003232A1 (en) | 2008-06-27 |
Family
ID=39170372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200703232A CL2007003232A1 (en) | 2006-11-10 | 2007-11-09 | COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS. |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP2086968B1 (en) |
JP (2) | JP4484965B2 (en) |
KR (1) | KR101118402B1 (en) |
CN (1) | CN101535305B (en) |
AR (1) | AR063788A1 (en) |
AT (1) | ATE544764T1 (en) |
AU (1) | AU2007318901B2 (en) |
BR (1) | BRPI0718862B8 (en) |
CA (1) | CA2668280C (en) |
CL (1) | CL2007003232A1 (en) |
CY (1) | CY1112696T1 (en) |
DK (1) | DK2086968T3 (en) |
ES (1) | ES2380388T3 (en) |
HK (1) | HK1136276A1 (en) |
HR (1) | HRP20120385T1 (en) |
IL (1) | IL198645A (en) |
MA (1) | MA30960B1 (en) |
MX (1) | MX2009004764A (en) |
MY (1) | MY148847A (en) |
NO (1) | NO344727B1 (en) |
NZ (1) | NZ577538A (en) |
PL (1) | PL2086968T3 (en) |
PT (1) | PT2086968E (en) |
RU (1) | RU2453546C2 (en) |
SI (1) | SI2086968T1 (en) |
TW (1) | TWI374138B (en) |
WO (1) | WO2008056335A1 (en) |
ZA (1) | ZA200904028B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
KR101101982B1 (en) | 2003-04-30 | 2012-01-02 | 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
DE10340485B4 (en) | 2003-09-03 | 2015-05-13 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Process for the preparation of oxazolidinone-quinolone hybrids |
US8158797B2 (en) | 2003-12-18 | 2012-04-17 | Morphochem Aktiengesellschaft Fur Kombinatorische Chemie | Oxazolidinone-quinolone hybrid antibiotics |
DE602004015158D1 (en) | 2003-12-18 | 2008-08-28 | Morphochem Ag Komb Chemie | OXAZOLIDINONE-CHINOLON HYBRID ANTIBIOTICS |
US8124623B2 (en) | 2006-11-10 | 2012-02-28 | Actelion Pharmaceuticals Ltd. | 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials |
WO2009136379A1 (en) * | 2008-05-09 | 2009-11-12 | Actelion Pharmaceuticals Ltd | 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases |
EP2776431B1 (en) * | 2011-11-08 | 2016-05-04 | Actelion Pharmaceuticals Ltd. | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives |
EP3003307B1 (en) | 2013-05-28 | 2020-11-11 | Morphochem GmbH | Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections |
LT3003289T (en) | 2013-05-28 | 2019-06-25 | Morphochem Gmbh | Administration of oxazolidinone-quinolone hybrid antibacterials |
WO2016079757A2 (en) * | 2014-11-19 | 2016-05-26 | Symed Labs Limited | Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives |
WO2017146246A1 (en) * | 2016-02-26 | 2017-08-31 | 大塚製薬株式会社 | Piperidine derivative |
US10087171B2 (en) | 2016-12-19 | 2018-10-02 | Actelion Pharmaceuticals Ltd | Crystalline forms of cadazolid |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1156597A3 (en) * | 1982-04-28 | 1985-05-15 | Е.И.Дюпон Де Немур Энд Компани (Фирма) | Method of obtaining 3-(n-alkylsulfonylphenyl) oxazolidinone derivatives or their pharmaceutically acceptable acid-additive salts |
US4461773A (en) * | 1982-09-15 | 1984-07-24 | E. I. Dupont De Nemours And Company | P-Oxooxazolidinylbenzene compounds as antibacterial agents |
US6608081B2 (en) * | 1999-08-12 | 2003-08-19 | Ortho-Mcneil Pharmaceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
US6413981B1 (en) * | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
DE60117861T2 (en) * | 2000-12-21 | 2006-11-02 | Pharmacia & Upjohn Co. Llc, Kalamazoo | ANTIMICROBIAL CHINOLON DERIVATIVES AND THEIR USE FOR THE TREATMENT OF BACTERIAL INFECTIONS |
CA2405532A1 (en) * | 2001-02-07 | 2002-08-22 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
CN100544719C (en) * | 2003-04-30 | 2009-09-30 | 莫弗凯姆联合化学股份公司 | Oxazolidone-quinoline hybrid antibiotics is used for preparing the purposes of the medicine for the treatment of anthrax and other infection |
KR101101982B1 (en) * | 2003-04-30 | 2012-01-02 | 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 | Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections |
DE602004015158D1 (en) * | 2003-12-18 | 2008-08-28 | Morphochem Ag Komb Chemie | OXAZOLIDINONE-CHINOLON HYBRID ANTIBIOTICS |
KR100854211B1 (en) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | Novel oxazolidinone derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same for antibiotics |
-
2007
- 2007-11-09 PT PT07827038T patent/PT2086968E/en unknown
- 2007-11-09 ES ES07827038T patent/ES2380388T3/en active Active
- 2007-11-09 NZ NZ577538A patent/NZ577538A/en unknown
- 2007-11-09 MY MYPI20091893A patent/MY148847A/en unknown
- 2007-11-09 SI SI200730902T patent/SI2086968T1/en unknown
- 2007-11-09 AT AT07827038T patent/ATE544764T1/en active
- 2007-11-09 TW TW096142564A patent/TWI374138B/en active
- 2007-11-09 AU AU2007318901A patent/AU2007318901B2/en active Active
- 2007-11-09 PL PL07827038T patent/PL2086968T3/en unknown
- 2007-11-09 MX MX2009004764A patent/MX2009004764A/en active IP Right Grant
- 2007-11-09 CA CA2668280A patent/CA2668280C/en active Active
- 2007-11-09 JP JP2009535864A patent/JP4484965B2/en active Active
- 2007-11-09 KR KR1020097010924A patent/KR101118402B1/en active Search and Examination
- 2007-11-09 CL CL200703232A patent/CL2007003232A1/en unknown
- 2007-11-09 RU RU2009121812/04A patent/RU2453546C2/en active
- 2007-11-09 WO PCT/IB2007/054557 patent/WO2008056335A1/en active Application Filing
- 2007-11-09 BR BRPI0718862A patent/BRPI0718862B8/en active IP Right Grant
- 2007-11-09 EP EP07827038A patent/EP2086968B1/en active Active
- 2007-11-09 CN CN2007800418985A patent/CN101535305B/en active Active
- 2007-11-09 DK DK07827038.6T patent/DK2086968T3/en active
- 2007-11-12 AR ARP070105031A patent/AR063788A1/en active IP Right Grant
-
2009
- 2009-05-07 IL IL198645A patent/IL198645A/en active IP Right Grant
- 2009-06-01 MA MA31939A patent/MA30960B1/en unknown
- 2009-06-09 ZA ZA200904028A patent/ZA200904028B/en unknown
- 2009-06-09 NO NO20092209A patent/NO344727B1/en unknown
-
2010
- 2010-01-27 JP JP2010016076A patent/JP5490553B2/en active Active
- 2010-03-16 HK HK10102760.2A patent/HK1136276A1/en unknown
-
2012
- 2012-04-24 CY CY20121100383T patent/CY1112696T1/en unknown
- 2012-05-08 HR HRP20120385TT patent/HRP20120385T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007003232A1 (en) | COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS. | |
CL2008001002A1 (en) | COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION. | |
CL2008001003A1 (en) | COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION. | |
CL2007003226A1 (en) | COMPOUNDS DERIVED FROM PIRIDINONA; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT CANCER. | |
BRPI0814593A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. | |
CL2007003565A1 (en) | COMPOUNDS DERIVED FROM REPLACED PIPERIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN HIV INFECTION. | |
CL2007002916A1 (en) | COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS. | |
CL2007003470A1 (en) | UREA DERIVATIVE COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE AS ANTIBACTERIALS. | |
CL2008002319A1 (en) | Compounds derived from pyrrolopyrimidine; pharmaceutical composition comprising said compounds; and its use to treat cancer. | |
CL2008000197A1 (en) | COMPOUNDS DERIVED FROM 2,4-DIAMINO PIRIMIDINA, ANTRANILAMIDE INHIBITORS OF CINASA AURORA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT CANCER. | |
CL2007001325A1 (en) | COMPOUNDS DERIVED FROM BICYCLES, CEPT INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HYPERLIPIDEMIA, ARTERIOESCLEROSIS, AMONG OTHER ILLNESSES. | |
CL2007002446A1 (en) | COMPOUNDS DERIVED FROM MORFOLINO PIRIMIDINA; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO PRODUCE AN ANTIPROLIFERING EFFECT. | |
BRPI0716171A2 (en) | compound, pharmaceutical composition and use of a compound. | |
CL2007002107A1 (en) | COMPOUNDS DERIVED FROM BENCIL PIPERIDIN-1-IL AMINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HYPERLIPIDEMIA, ARTERIOESCLEROSIS, ATEROSCLEROSIS, PERIPHERAL VASCULOPATHY, DYSLIPIDEMIA, AMONG OTHER DISEASES. | |
BRPI0815170A2 (en) | Pharmaceutical composition comprising an sglt 2 inhibitor | |
BRPI0815709A2 (en) | composition, pharmaceutical composition, and use of a compound. | |
CL2007003138A1 (en) | COMPOUNDS DERIVED FROM ANILINOPIPERAZINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER. | |
BRPI0818804A2 (en) | Pyrimidine derivative compound, pharmaceutical composition comprising it and use of such compound. | |
BRPI0815190A2 (en) | Pyridine derivative compound, pharmaceutical composition comprising it and use thereof | |
BRPI0815079A2 (en) | 1,2-DIAMIDE-ETHYLENE DERICTED COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THIS COMPOUND | |
BRPI0908208A2 (en) | Oxazolidinone derivative compound, drug, pharmaceutical composition containing it and use of such compound. | |
CL2007003645A1 (en) | PARASITICIDE COMPOUNDS DERIVED FROM SUBSTITUTED ARIL-PIRAZOLES; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A PARASITARY INFECTION. | |
BRPI0907892A2 (en) | Azatricyclic antibiotic compound, medicine, pharmaceutical composition containing and use thereof | |
CL2007002021A1 (en) | COMPOUNDS DERIVED FROM OXOISOINDOL; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM; AND ITS USE TO TREAT ARRITMIAS. | |
CL2007001630A1 (en) | COMPOUNDS DERIVED FROM PIRROLIDINAMIDE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF HEPATITIS C. |